Inventor
Xiaoli Cui
Inventor
Memphis, TN, US
Overview
Patents· 2 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides20%
C12NMicroorganisms or enzymes20%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms20%
G01NInvestigating or analysing materials by determining their chemical or physical properties20%
PatentTitleYear
9,458,508'Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors'20168,383,793'Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors'2013Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2013Patents assigned to CUI XIAOLI (1)· patent assignee history
2013Patents assigned to JIANG QIN (1)· patent assignee history
2013Patents assigned to MORRIS STEPHAN W (1)· patent assignee history
2013Patents assigned to ST JUDE CHILDRENS RES HOSPITAL (1)· patent assignee history
2013–2016Based in Memphis, TN, US· patent location history
2016Patents assigned to ST JUDE CHILDREN'S RES HOSPITAL (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CUI XIAOLIself | 1 | 2013 |
| JIANG QIN | 1 | 2013 |
| MORRIS STEPHAN W | 1 | 2013 |
| ST JUDE CHILDREN'S RES HOSPITAL | 1 | 2016 |
| ST JUDE CHILDRENS RES HOSPITAL | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Memphis, TN, US | 2 | 2013–2016 |